Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) rose 9.6% during trading on Wednesday . The stock traded as high as $1.4360 and last traded at $1.4360. Approximately 620 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 11,528 shares. The stock had previously closed at $1.31.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Akso Health Group in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.
Read Our Latest Research Report on AHG
Akso Health Group Stock Performance
Institutional Trading of Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC purchased a new position in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is currently owned by hedge funds and other institutional investors.
About Akso Health Group
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Recommended Stories
- Five stocks we like better than Akso Health Group
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- 1,500 Banks Just Handed the Fed Your Bank Account
- 3 Signs You May Want to Switch Financial Advisors
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
